Healthcare Brain Medication NER — Medication & Drug Entity Extraction by Genzeon Platform
Healthcare Brain Medication NER is a transformer-based clinical Named Entity Recognition model developed by Genzeon Platforms for automated extraction of medication names, dosages, routes, frequencies, and administration details from unstructured clinical text. Built on Bio_ClinicalBERT and fine-tuned on clinical medication corpora, this model delivers production-grade entity recognition across 12 medication and drug entity categories.
Model Details
Property
Value
Developed by
Genzeon Platforms
Base model
Bio_ClinicalBERT
Architecture
BERT Token Classification (BIO tagging)
Parameters
~110M
Tagging scheme
BIO (25 labels)
Max sequence length
512 tokens
Framework
HuggingFace Transformers
License
Apache-2.0
Intended Use
Healthcare Brain Medication NER is designed for healthcare AI pipelines that need to extract structured medication information from unstructured clinical text. Primary use cases include:
Medication extraction — extracting drug names, dosages, routes, and frequencies from EHRs, discharge summaries, progress notes, and clinical narratives.
Prescription parsing — automated order entry and clinical decision support from free-text medication orders.
Adverse drug event detection — identifying medication-related adverse reactions for pharmacovigilance and safety surveillance workflows.
Medication reconciliation — structured extraction across care transitions, enabling automated reconciliation between inpatient and outpatient regimens.
Clinical research — extracting medication-related entities from large corpora of clinical narratives for retrospective drug utilization studies.
Entity Types
The model recognizes 12 medication and drug entity types using BIO tagging (25 labels total):
Category
Entity Type
Description
Examples
Drug
DRUG_NAME
Brand or generic medication name
Metformin, Lipitor, amoxicillin
Dosing
DOSAGE
Amount to administer
1 tablet, 2 puffs, 10 mL
Potency
STRENGTH
Drug concentration/potency
500 mg, 10 mg/5 mL, 0.5%
Administration
ROUTE
Route of administration
oral, IV, PO, topical, inhaled
Schedule
FREQUENCY
Dosing schedule
BID, once daily, q6h, PRN
Temporal
DURATION
Length of therapy
for 7 days, x 2 weeks, indefinitely
Formulation
FORM
Physical dosage form
tablet, capsule, injection, cream
Status
DRUG_STATUS
Current medication status
active, discontinued, on hold
Indication
REASON
Clinical indication for use
for hypertension, for pain
Safety
ADVERSE_REACTION
Side effects or adverse drug events
rash, nausea, anaphylaxis
Identifier
NDC_CODE
National Drug Code
00093-7214-01
Identifier
RxNorm_CODE
RxNorm concept identifier
197361
Note: External dataset loaders (n2c2 2018 Track 2, i2b2 2009 Medication) are architecturally supported and included in this release. These datasets require Data Use Agreements from Harvard DBMI and i2b2.org respectively. Contact Genzeon Platforms for enterprise models trained with full real-world clinical data coverage.
1from transformers import pipeline
23# Load the model4nlp = pipeline(5"token-classification",6 model="genzeonplatform/healthcare-brain-medication-ner",7 aggregation_strategy="simple",8)910# Process clinical text11text ="""Discharge medications: Continue Metformin 500 mg tablet by mouth twice daily
12for diabetes. New: Amoxicillin 500 mg capsule PO TID for 7 days for sinusitis.
13Discontinue Lisinopril due to persistent cough."""1415entities = nlp(text)16for ent in entities:17print(f" [{ent['entity_group']:20s}] {ent['word']} (score: {ent['score']:.3f})")
1from transformers import pipeline
23nlp = pipeline(4"token-classification",5 model="genzeonplatform/healthcare-brain-medication-ner",6 aggregation_strategy="simple",7)89clinical_notes =[10"Start Atorvastatin 40 mg tablet PO at bedtime for high cholesterol.",11"ADR: Patient developed rash after Penicillin IV. Drug discontinued.",12"Albuterol 90 mcg inhaler 2 puffs inhaled Q4-6H PRN for bronchospasm.",13"MAR: Administered Vancomycin 1 g IV Q12H. NDC: 00409-6509-01.",14]1516for note in clinical_notes:17 entities = nlp(note)18print(f"Text: {note[:70]}...")19for ent in entities:20print(f" [{ent['entity_group']:18s}] {ent['word']}")21print()
Structured Output
python
1from transformers import pipeline
2import json
34nlp = pipeline(5"token-classification",6 model="genzeonplatform/healthcare-brain-medication-ner",7 aggregation_strategy="simple",8)910text ="Rx: Omeprazole 20 mg capsule PO once daily for GERD x 30 days. NDC: 00186-5020-31."11entities = nlp(text)1213# Structured extraction14structured =[15{16"text": ent["word"],17"type": ent["entity_group"],18"score":round(ent["score"],4),19"start": ent["start"],20"end": ent["end"],21}22for ent in entities
23]2425print(json.dumps(structured, indent=2))
Training Details
Developed by: Genzeon Platforms
Base model: Bio_ClinicalBERT (domain-specialized BERT for clinical text, pre-trained on PubMed + MIMIC-III)
NER architecture: BertForTokenClassification (768 → 25 linear head)
Training data: Synthetic clinical medication corpus + BC5CDR-Chemical
Epochs: 15 (early stopping, patience=3)
Learning rate: 3e-5 (linear schedule with warmup, 10% warmup ratio)
Entity mapping: n2c2 2018 entity types are mapped to target categories (Drug→DRUG_NAME, Strength→STRENGTH, Dosage→DOSAGE, Route→ROUTE, Frequency→FREQUENCY, Duration→DURATION, Form→FORM, ADE→ADVERSE_REACTION, Reason→REASON). BC5CDR Chemical entities map to DRUG_NAME.
Limitations
English only: Currently optimized for English clinical and biomedical text. Multilingual support is on the Genzeon Platforms roadmap.
Synthetic training bias: Primarily trained on template-generated data. Performance on highly variable real-world clinical documentation may differ — contact Genzeon Platforms for enterprise models fine-tuned with restricted clinical datasets (n2c2, i2b2).
Multi-word drug names: Compound drug names (e.g., "amoxicillin/clavulanate", "Advair Diskus") may have partial boundary detection depending on WordPiece tokenization.
Contextual ambiguity: REASON vs. ADVERSE_REACTION can be contextually ambiguous (e.g., "nausea" as an indication for antiemetics vs. a side effect of another drug). Context window and surrounding entities improve disambiguation.
Code entities: NDC_CODE and RxNorm_CODE require specific formatting context (typically preceded by "NDC:" or "RxNorm:"); isolated numeric strings may not be recognized.
Human-in-the-loop recommended: For clinical decision-making and patient safety workflows, pair model predictions with expert pharmacist or clinician review.
Related Genzeon Platforms Models
Healthcare Brain NER — PHI/PII detection and de-identification. 20 PHI categories.
Healthcare Brain Clinical Findings NER — Transformer-based clinical NER model for extraction of clinical findings, diseases, conditions, anatomical locations, and clinical modifiers from clinical text. 8 clinical finding categories, F1: 0.6209 (strict) / 0.968 (relaxed).
About Genzeon Platforms
Genzeon Platforms is a healthcare technology company that is building the agentic AI decision infrastructure for healthcare. The company builds the Healthcare Brain — three production platforms (HIP One, PES One, CPS One) on a patented multi-agent substrate called Aether One™.
Production Deployment
Genzeon Platforms is a participant in the CMS WISeR Innovation Model (2026–2031), operating Medicare FFS prior authorization in New Jersey under MAC JL via Novitas Solutions. Live since January 1, 2026.
Q1 2026 production results:
15k+ cases processed
100% three-day TAT compliance
Zero auto-denials (every non-affirmation signed by a named licensed clinician)
42% reviewer productivity gain
Sub-three-minute median decision latency
85% portal channel adoption
Scale
50+ payer and provider clients across the Genzeon Platforms
1M+ Medicare FFS members served under WISeR
Patent Portfolio
12 USPTO provisional applications filed covering the Aether One™ architecture
Supports on-premises, sovereign-cloud, and air-gapped deployments via the Knowledge Containment Architecture (KCA) reference design
Partnerships
10-year Microsoft partnership (5 partner designations, Microsoft Healthcare Agent Service integration, Dragon Copilot extension)
UiPath Platinum (Top 3 HLS)
Available on:
Azure Marketplace
AWS Marketplace
Google Cloud Marketplace
Salesforce AppExchange
Open Specifications
Genzeon Platforms publishes the Aether Knowledge Pack Specification (AKPS). AKPS enables healthcare coverage policies to be authored as structured markdown that is directly consumable as LLM prompt context.
Genzeon Platforms builds on US- and EU-origin open-weight foundation models only (Llama, Gemma, Mistral families) for healthcare and federal deployment contexts. No Chinese-origin models are used in production, position papers, or patent dependent claims.
If you use this model or reference Genzeon Platforms in academic, regulatory, or industry work, please cite:
Genzeon Platforms (2026). Healthcare Brain Medication NER is part of Genzeon Platform's suite of healthcare AI tools designed to accelerate clinical research and improve patient care.
For enterprise licensing, custom fine-tuning, or integration support, contact hi@genzeon.one.